Promotion of regulatory T cell induction by immunomodulatory herbal medicine licorice and its two constituents
Ao Guo, Dongming He, Hong-Bo Xu, Chang-An Geng, Jian Zhao, Ao Guo, Dongming He, Hong-Bo Xu, Chang-An Geng, Jian Zhao
Abstract
Regulatory T cells (Treg) play a critical role to control immune responses and to prevent autoimmunity, thus selective increase of Treg cells in vivo has broad therapeutic implications for autoimmune and inflammatory diseases. Licorice is a well-known herbal medicine used worldwide for over thousands of years, and accumulating evidence has shown its immunomodulatory potential. However, it is not clear whether licorice could regulate the induction and function of Treg cells. Here we found licorice extract could promote Treg cell induction, and then we used a rational approach to isolate its functional fractions and constituents. The results showed that two constituents, isoliquiritigenin and naringenin, promoted Treg cell induction both in vitro and in vivo. The effective fractions and two constituents of licorice also enhanced immune suppression of Treg cells, and they further reduced severity of DSS-induced colitis in mice. This study suggested that promotion of regulatory T cell induction could be an underlying mechanism of the historically and widely used herbal medicine licorice, providing its two effective molecules against autoimmune and inflammatory diseases.
Figures
References
- Ohkura N., Kitagawa Y. & Sakaguchi S. Development and maintenance of regulatory T cells. Immunity 38, 414–23 (2013).
- Sakaguchi S., Yamaguchi T., Nomura T. & Ono M. Regulatory T Cells and Immune Tolerance. Cell (2008). 10.1016/j.cell.2008.05.009.
- Cebula A. et al. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 497, 258–62 (2013).
- Huynh A., Zhang R. & Turka L. A. Signals and pathways controlling regulatory T cells. Immunol. Rev. 258, 117–31 (2014).
- Atarashi K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232–6 (2013).
- Smith P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569–73 (2013).
- Trompette A. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. (2014). 10.1038/nm.3444.
- von Boehmer H. & Daniel C. Therapeutic opportunities for manipulating TReg cells in autoimmunity and cancer. Nature Reviews Drug Discovery (2012). 10.1038/nrd3683
- Miyara M., Ito Y. & Sakaguchi S. TREG-cell therapies for autoimmune rheumatic diseases. Nat Rev Rheumatol 10, 543–51 (2014).
- Zheng Y. & Rudensky A. Y. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8, 457–62 (2007).
- Feuerer M., Hill J., Mathis D. & Benoist C. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nature Immunology (2009). 10.1038/ni.1760
- Chen W. et al. Conversion of peripheral CD4+CD25– naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875–86 (2003).
- Josefowicz S. Z., Lu L.-F. F. & Rudensky A. Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531–64 (2012).
- Miskov-Zivanov N., Turner M. S., Kane L. P., Morel P. A. & Faeder J. R. The duration of T cell stimulation is a critical determinant of cell fate and plasticity. Sci Signal 6, ra97 (2013).
- Sauer S. et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA 105, 7797–802 (2008).
- Haxhinasto S., Mathis D. & Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205, 565–74 (2008).
- Horn D., Hess J., Freier K., Hoffmann J. & Freudlsperger C. Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma. Expert Opin. Ther. Targets 1–11 (2015). 10.1517/14728222.2015.1012157
- Crellin N. K., Garcia R. V. & Levings M. K. Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. Blood 109, 2014–22 (2007).
- Fiore C., Eisenhut M., Ragazzi E., Zanchin G. & Armanini D. A history of the therapeutic use of liquorice in Europe. J Ethnopharmacol 99, 317–24 (2005).
- Zhang Q. & Ye M. Chemical analysis of the Chinese herbal medicine Gan-Cao (licorice). J Chromatogr A 1216, 1954–69 (2008).
- Honda H. et al. Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation. J. Leukoc. Biol. 96, 1087–100 (2014).
- Honda H. et al. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner. J. Leukoc. Biol. 91, 967–76 (2012).
- Kim J.-Y. Y. et al. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages. Eur. J. Pharmacol. 584, 175–84 (2008).
- Akamatsu H., Komura J., Asada Y. & Niwa Y. Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation. Planta Med. 57, 119–21 (1991).
- Takahashi T. et al. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci. 95, 448–53 (2004).
- Ma C. et al. Immunoregulatory effects of glycyrrhizic acid exerts anti-asthmatic effects via modulation of Th1/Th2 cytokines and enhancement of CD4(+)CD25(+)Foxp3+ regulatory T cells in ovalbumin-sensitized mice. J Ethnopharmacol 148, 755–62 (2013).
- Bilate A. M. & Lafaille J. J. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu. Rev. Immunol. 30, 733–58 (2012).
- Serres D., Sayegh & Najafian. Immunosuppressive Drugs and Tregs: A Critical Evaluation! Clinical Journal of the American Society of Nephrology (2009). 10.2215/CJN.03180509
- Khalid S. A., Yagi S. M., Khristova P. & Duddeck H. (+)-Catechin-5-galloyl Ester as a Novel Natural Polyphenol from the Bark of Acacia nilotica of Sudanese Origin1. Planta Med. 55, 556–8 (1989).
- Aida K. et al. Isoliquiritigenin: a new aldose reductase inhibitor from glycyrrhizae radix. Planta Med. 56, 254–8 (1990).
- Wang H.-K. K. et al. Dietary flavonoid naringenin induces regulatory T cells via an aryl hydrocarbon receptor mediated pathway. J. Agric. Food Chem. 60, 2171–8 (2012).
- Quintana F. J. et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65–71 (2008).
- Powell J. D., Pollizzi K. N., Heikamp E. B. & Horton M. R. Regulation of immune responses by mTOR. Annu. Rev. Immunol. 30, 39–68 (2012).
- Barbi J., Pardoll D. & Pan F. Metabolic control of the Treg/Th17 axis. Immunol. Rev. 252, 52–77 (2013).
- Li Y. et al. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. Toxicol. Appl. Pharmacol. 272, 37–48 (2013).
- Asl M. N. & Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22, 709–24 (2008).
- Shibata S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 120, 849–62 (2000).
- Weinberg D. S., Mainer L. M., Richardson M. D. & Haibach F. G. Identification and quantification of isoflavonoid and triterpenoid compliance markers in a licorice-root extract powder. Journal of Agricultural and Food Chemistry 41, 42–47 (1993).
Source: PubMed